Wednesday, July 8, 2026

Drug profile · INN

methyltestosterone

methyltestosterone (METHYLTESTOSTERONE) is a androgen receptor agonist. Route of administration: buccal. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — methyltestosterone
US status
approved
Class
Route
BUCCAL
Patents
0
Programs
1
Data quality
0.84

Quick answer

methyltestosterone (METHYLTESTOSTERONE) is a androgen receptor agonist. Route of administration: buccal. Current US regulatory status: approved.

Key facts

INN methyltestosterone
Brand METHYLTESTOSTERONE
Mechanism Androgen Receptor agonist
Target Androgen receptor
Route BUCCAL
Formulation CAPSULE

Mechanism of action

Androgen Receptor agonist

Primary target: Androgen receptor

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. N-methyl glycine Phase 2 · Chinese Academy of · Obsessive Compulsive Disorder

Related & competitor drugs

  1. bicalutamide Androgen Receptor antagonist
  2. danazol Progesterone receptor agonist
  3. nandrolone decanoate Androgen Receptor agonist
  4. testosterone Genito-urinary system and sex hormones (G03)
  5. testosterone cypionate Androgen Receptor agonist
  6. apalutamide Antineoplastic and immunomodulating agents (L02)

Frequently asked questions

What is methyltestosterone?

methyltestosterone (METHYLTESTOSTERONE) is a androgen receptor agonist. Route of administration: buccal. Current US regulatory status: approved.

What is the brand name for methyltestosterone?

METHYLTESTOSTERONE is a marketed brand name for methyltestosterone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of methyltestosterone?

methyltestosterone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.